Liposomal-All-trans-Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia

By  

Current Cancer Therapy Reviews, Vol. 1, Iss. 3, 2005-11 ,pp. : 239-250

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment outcomes in relapsed acute promyelocytic leukemia patients initially treated with alltrans retinoic acid and arsenic compoundbased combined therapies

By            

Oncology Letters, Vol. 7, Iss. 1, 2014-01 ,pp. : 177-182

Spandidos Publications

Access to resources Recommend Favorite

Treatment with valproic acid, all-trans retinoic acid (ATRA) and theophyllamine for 9 days caused a persistent increase in peripheral blood platelet counts for a patient with acute myelogenous leukemia

By Stapnes Camilla   Ryningen Anita   Tore Gjertsen Bjørn   Bruserud Øystein  

Acta Oncologica, Vol. 45, Iss. 3, 2006-04 ,pp. : 346-349

Informa Healthcare

Access to resources Recommend Favorite

Changes in expression of WT1 during induced differentiation of the acute myeloid leukemia cell lines by treatment with 5-aza-2'-deoxycytidine and all-trans retinoic acid

By                  

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 1521-1526

Spandidos Publications

Access to resources Recommend Favorite

Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A

By                

Oncology Reports, Vol. 28, Iss. 5, 2012-01 ,pp. : 1875-1882

Spandidos Publications

Access to resources Recommend Favorite